GGrantIndex
← Leaderboards

Henry Rodriguez

Indiana Univ-Purdue Univ At Indianapolis

$4,461,531
Attributed
$4,873,163
Total exposure
21
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1M · FY200518
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$4,873,163 · 21

By mechanism

U01$4,616,169 · 3
M01$256,994 · 18

Top collaborators

Most similar at Indiana Univ-Purdue Univ At Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Insulin

Research focus

InsulinDiabetes MellitusInsulin Dependent Diabetes MellitusFundingClinical TrialsClinical ResearchHuman SubjectCell PhysiologyParticipantDisease /Disorder Prevention /ControlDiabetes Mellitus, Insulin-DependentPreventDesignResourcesImmunologicsImmunoregulationIndianaAutoantibodiesIntervention TrialBeta CellB-LymphocytesComputer Retrieval Of Information On Scientific Projects DatabaseCaringGrant

Grant awards (37)

USF TrialNet Clinical Center$1
U01 · FY2018 · DK · contact PI
USF TrialNet Clinical Center$266,270
U01 · FY2017 · DK · contact PI
USF TrialNet Clinical Center$266,270
U01 · FY2016 · DK · contact PI
USF TrialNet Clinical Center$266,271
U01 · FY2015 · DK · contact PI
USF TrialNet Clinical Center$411,342
U01 · FY2014 · DK · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$823,264
U01 · FY2009 · DK · contact PI
NATURAL HISTORY OF THE DEVELOPMENT OF TYPE 1 DIABETES$5,860
M01 · FY2008 · RR · contact PI
NEW ONSET OF TYPE 1 DIABETES MYCOPHENOLATE MOFETIL - DACLIZUMAB CLINICAL TRIAL$1,599
M01 · FY2008 · RR · contact PI
TYPE 1 DIABETES TRIALNET PROTOCOL TN-05 / EFFECTS OF RITUXIMAB ON THE PROGRESS$363
M01 · FY2008 · RR · contact PI
Type 1 Diabetes TrialNet at Indiana University Clinical Center$942,866
U01 · FY2007 · DK · contact PI
NATURAL HISTORY OF THE DEVELOPMENT OF TYPE 1 DIABETES$68,965
M01 · FY2007 · RR · contact PI
NEW ONSET OF TYPE 1 DIABETES MYCOPHENOLATE MOFETIL - DACLIZUMAB CLINICAL TRIAL$18,824
M01 · FY2007 · RR · contact PI
TYPE 1 DIABETES TRIALNET PROTOCOL TN-05 / EFFECTS OF RITUXIMAB ON THE PROGRESS$4,278
M01 · FY2007 · RR · contact PI
NATURAL HISTORY OF THE DEVELOPMENT OF TYPE 1 DIABETES$69,087
M01 · FY2006 · RR · contact PI
NEW ONSET OF TYPE 1 DIABETES MYCOPHENLATE MOFETIL - DACLIZUMAB CLINICAL TRIAL$8,080
M01 · FY2006 · RR · contact PI
IMPROVING METABOLIC ASSESSMENTS IN TYPE 1 DIABETES MELLITUS CLINICAL TRIALS$6,666
M01 · FY2006 · RR · contact PI
TYPE 1 DIABETES GENETICS CONSORTIUM$4,646
M01 · FY2006 · RR · contact PI
Type 1 Diabetes TrialNet Indiana University Clinical Ce*$1
U01 · FY2006 · DK · contact PI
Type 1 Diabetes TrialNet Indiana University Clinical Ce*$541,986
U01 · FY2005 · DK
NATURAL HISTORY OF THE DEVELOPMENT OF TYPE 1 DIABETES$61,630
M01 · FY2005 · RR
TYPE 1 DIABETES GENETICS CONSORTIUM$3,534
M01 · FY2005 · RR
NEW ONSET OF TYPE 1 DIABETES MYCOPHENLATE MOFETIL - DACLIZUMAB CLINICAL TRIAL$221
M01 · FY2005 · RR
Type 1 Diabetes TrialNet Indiana University Clinical Ce*$277,896
U01 · FY2004 · DK
F/U of People w/Increased Risk of Diabetes who had Participated in DPT1 trial$1,246
M01 · FY2004 · RR
Diabetes Prevention Trial-Type I Diabetes:Parenteral Insulin to Prevent Diabetes$997
M01 · FY2004 · RR
Metabolic and Immunogenetic Evaluation of Relatives w/type 1 Diabetes$499
M01 · FY2004 · RR
Follow-up of People with Increased Risk of Type I Diabetes$499
M01 · FY2004 · RR
Type 1 Diabetes TrialNet Indiana University Clinical Ce*$259,352
U01 · FY2003 · DK
Type 1 Diabetes TrialNet Indiana University Clinical Ce*$273,244
U01 · FY2002 · DK
DIABETES PREVENTION TRIAL TYPE I DIABETES--STAGING$0
M01 · FY2002 · RR
Type 1 Diabetes TrialNet at Indiana University$287,406
U01 · FY2001 · DK
DIABETES PREVENTION TRIAL TYPE I DIABETES--STAGING$0
M01 · FY2001 · RR
DIABETES PREVENTION TRIAL TYPE I DIABETES--STAGING$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL TYPE I DIABETES--STAGING$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL TYPE I DIABETES--STAGING$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL TYPE I DIABETES--STAGING$0
M01 · FY2000 · RR
DIABETES PREVENTION TRIAL TYPE I DIABETES--STAGING$0
M01 · FY2000 · RR